Claritas Genomics is a CLIA-certified genetic diagnostic laboratory that uses advanced genetic analysis technology in conjunction with the experience of leading pediatricians across the globe. Claritas mainly focuses in healthcare industries that work in the area of genetic diagnosis and provides quality services for the enhancement of the services provided to patients.
History
Formerly a laboratory of Boston Children’s Hospital, Claritas is now an independent laboratory since 2013. Founded to serve physicians, researchers, and hospitals in genetic testing, Claritas grew into a premier commercial diagnostic company at Cambridge, Massachusetts. These strategic investors are – Cincinnati Children’s Hospital, Thermo Fisher, Cerner Corporation, and WuXi-NextCODE.
Location
Claritas Genomics is located at:
99 Erie Street, Cambridge, Massachusetts 02139
Contact Information
For client inquiries, please call:
(617) 553 – 5880
Services
Claritas provides many different types of genetic diagnostic tests starting with single gene analysis up to whole exome sequencing. The lab also has interpretive services, which help clinicians in the understand of various genetic details. Payment options include IVR, payment by post, and physical payments. There are programs that entail financially supporting those patients in need.
Awards and Achievements
Claritas is on scientific advancement, and we work alongside clinicians and researchers to come up with findings that will result in new tests and clinical knowledge in the field of pediatric genomics. ISO 15189 accreditation, CLIA certification, and several state licenses support the fact that the company provides high-quality service.
Who we are
Claritas is a genetic diagnostic laboratory that has the goal of providing the highest quality testing services for diagnosis of pediatric disorders. Originating as the in-house genetic testing lab at Boston Children’s Hospital, Claritas was launched as a stand-alone entity in February 2013, and in October 2013, Cincinnati Children’s Hospital joined us, beginning the formation of a genomic network of pediatric hospitals.
Testing Services
Claritas offers services that support all aspects of the clinical testing experience, from test ordering to providing the most reliable and up-to-date clinical report for each patient. Our tests are derived from the clinical expertise at pediatric hospitals and, if requested, we can connect our clients to subject matter experts for follow-up.
Educational Resources
As part of our mission to partner with health care providers to improve patient care, Claritas Genomics is deeply committed to creating resources that further our community’s knowledge about genetics and genomics. Check back often as our content will continue to grow.
Send Out Management
Claritas can act as a single point of contact and interface for your institution’s reference lab send-outs, for negotiating volume discounts, streamlined ordering, sample shipping, test status reporting and results return. For more on send out management please contact us.
Team:
Patrice M. Milos, Ph.D.
Dr. Patrice Milos is an inspiring advocate of precision health, combining her extensive experience in scientific operations and innovative technology to give individuals the power to make educated decisions about their wellbeing. Most notably, she co-founded Claritas Genomics – a testament to her pioneering spirit when it comes to preventive medicine. As Vice President at Proof Diagnostics, she continues this mission with dedication and passion every day.
David Miller, MD, PhD, FACMG
David Miller is a highly accomplished medical geneticist who holds numerous degrees and credentials, including an MD, PhD, and FACMG. He currently serves as one of our Medical Directors at Claritas Genomics while simultaneously working as an Associate Professor of Pediatrics for Harvard Medical School. Dr Miller’s rare blend of clinical experience–where he both orders genetics tests and communicates the results directly to patients – alongside in-depth knowledge regarding laboratory diagnostics makes his insight invaluable.
Yiping Shen, PhD FACMG
Yipping Shen PhD FACMG is an accomplished medical director and leads a talented research & development group at Claritas while drawing on decades of human genetic experience. He has expertise in the application of various tests such as MLPA, microarray-based CNV+SNP test, Sanger Sequencing and Next Generation Sequencing during his tenure with Boston Children’s Hospital Genetic Diagnostic Laboratory (GDL).
Louis M. Kunkel, PhD
With a B.A. from Gettysburg College and Ph.D, Johns Hopkins University under his belt, Dr Kunkel is an internationally renowned geneticist with over 30 years of experience in muscular dystrophies research field – universally recognized for uncovering the genes responsible for the disorder as far back as 1986 when he identified ‘dystrophin’ to be its causative gene. His lifelong dedication has seen him work toward understanding molecular bases behind neuromuscular disorders while exploring potential treatment alternatives.
Our Partners:
Our Certificates:
